Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -

Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.

Key features of the study:

  • This report provides in-depth analysis of the Global Nanomedicines market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Nanomedicines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market
Detailed Segmentation:
  • Global Nanomedicines Market, By Application:
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • Global Nanomedicines Market, By Region:
  • North America
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • By Application
  • Cardiovascular
  • Anti-inflammatories
  • Anti-infectives
  • Neurology
  • Oncology
  • Others (dental, orthopedic, urology, ophthalmic)
  • By Country
  • North Africa
  • Central Africa
  • South Africa
  • Company Profiles
  • Abbott Laboratories *
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
  • CombiMatrix Corporation
  • Clene Nanomedicine, Inc.
  • Cellics Therapeutics Inc.
  • Nanobiotix S.A
  • Celgene Corporation
  • GE Healthcare
  • NanoViricides, Inc.
  • Johnson & Johnson
  • Mallinckrodt plc.
  • Sirnaomics Inc.
  • Precision NanoSystems Inc.
  • Merck & Company Inc.
  • Nanosphere, Inc.
  • Pfizer Inc.
  • Sigma-Tau Pharmaceuticals Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Application
Market Snippet, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
4. Global Nanomedicines Market, By Application, 2019 – 2027, (US$ Bn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Anti-inflammatories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Others (dental, orthopedic, urology, opthalmic)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
5. Global Nanomedicines Market, By Region, 2019 – 2027, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
U.S.
Canada
Latin America
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
Germany
U.K.
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
North Africa
Central Africa
South Africa
6. Competitive Landscape
Company Profiles
Abbott Laboratories
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
CombiMatrix Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Clene Nanomedicine, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Cellics Therapeutics Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Nanobiotix S.A
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Celgene Corporation
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
GE Healthcare
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
NanoViricides, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Mallinckrodt plc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sirnaomics Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Precision NanoSystems Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Company Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Nanosphere, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sigma-Tau Pharmaceuticals Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
7. Section
References
Research Methodology
About us and Sales Contact
*Browse 22 market data tables and 14 figures on “Nanomedicines Market - Global forecast to 2027”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook